SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Cacaito who wrote (13970)7/4/2000 6:46:46 PM
From: Robert K.  Respond to of 17367
 
cacaito, read again. I question you investigative thoroughness. Prove me wrong.



To: Cacaito who wrote (13970)7/4/2000 6:50:26 PM
From: Cacaito  Read Replies (2) | Respond to of 17367
 
And you made me sound like a dismal doom theory about xoma!

No one seems to recognized when I conceded to certain prospects!

Even, when I argue about competition is not dismal outlook, just reality.



To: Cacaito who wrote (13970)7/4/2000 6:54:30 PM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
Cacaito, YOU ARE NOT UP TO THE CHALLENGE!!!!!! What was in those fresh 2 pints THAT EVERYONE GOT????? DUH!!!!!! Does natural BPI ring a bell???? HELLO??????



To: Cacaito who wrote (13970)7/4/2000 7:02:45 PM
From: Robert K.  Respond to of 17367
 
Actually your comment ". the leftover bpi in transfusions? xoma was dealing with pharmacological supraphysiologic doses1"
that is the ONLY possible explaintion i can see. And that
DOES NOT prove me wrong. try again.